Skip to content


Harry Cassin
Publisher and Editor

Andy Spalding
Senior Editor

Jessica Tillipman
Senior Editor

Bill Steinman
Senior Editor

Richard L. Cassin
Editor at Large

Elizabeth K. Spahn
Editor Emeritus

Cody Worthington
Contributing Editor

Julie DiMauro
Contributing Editor

Thomas Fox
Contributing Editor

Marc Alain Bohn
Contributing Editor

Bill Waite
Contributing Editor

Russell A. Stamets
Contributing Editor

Richard Bistrong
Contributing Editor

Eric Carlson
Contributing Editor

Resource Alert: China Pharma, Medical News

China Compliance Digest: Rx Edition is a weekly compendium of recent news stories about corruption and enforcement in China’s pharmaceutical and medical industries.

This newsletter was designed to provide an insider’s view of the compliance challenges experienced by foreign companies working within these industries in China. In addition, our coverage will alert you to emerging risks and potentially compromising situations as they evolve.

Our writers scour Chinese-language sources to bring you timely information on issues rarely covered in the Western media.

The inaugural issue of China Compliance Digest: Rx Edition compiles relevant stories that have appeared in the newsletter over the past few months. New information has been added to bring the stories up to date.

Click now for a free trial subscription:


Share this post


Comments are closed for this article!